Parties Will Jointly Develop MP0310, a Pre-clinical FAP x 4-1BB MultiSpecific DARPin® Molecule, in Combination with Amgen’s Oncology Assets, Including BiTE® Molecules Molecular Partners Retains Rights to Develop MP0310 in Combination With its Pipeline Products ZURICH-SCHLIEREN, SWITZERLAND and THOUSAND OAKS, Calif.– (Dec. 19, 2018) – Molecular Partners AG (SIX: [...]
Located in Basel, Switzerland, Medartis develops, manufactures and distributes medical internal fixation devices and surgical instruments offered in system solutions for small bone fractures focusing on the extremities. The company was founded in 1997 by Dr. Thomas Straumann and employs more than 500 people on 12 sites, and its [...]
Advanced technology offers potential to become a new standard of care for fibroid treatment Redwood City, CA – August 22, 2018 – Gynesonics, a women’s healthcare company focused on the development of minimally-invasive solutions for symptomatic uterine fibroids, today announced that it has received 510(k) clearance from the U.S. [...]
US launch expected in mid-2019 – July 17, 2018 In a major positive for CeQur, the European insulin delivery start-up has acquired Calibra Finesse (One Touch Via) from J&J, the highly-anticipated three-day-wear, bolus-only (2-unit), 510(k)-cleared, super slim disposable insulin patch device. A US launch is expected in mid-2019 via [...]
Symetis spinout Polares Medical unlocked $25 million in venture capital financing to continue development of its mitral valve repair/replacement system and enter clinical testing. The Lausanne, Switzerland-based company’s device—a transcatheter, hemi-replacement system currently in the preclinical stages—aims to treat mitral regurgitation, caused by the leakage of blood backward through [...]
Company to open corporate headquarters in Minneapolis, MN Minneapolis, MN – June 26, 2018 – Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), announced today the completion of a $58 million equity financing. The round was led by Endeavour Vision and [...]
Milan – Italy, June 16, 2018: SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today at the European Human Genetics Conference (ESHG 2018) that it has completed the acquisition of French-based tech company Interactive Biosoftware (IBS), the creators of Alamut®, the most used decision support software for clinical genomic [...]
Symetis grows and invests on its Ecublens site – article from AGEFI Symetis posted a 50% growth in 2017 and wants to strengthen its capabilities in Ecublens. La société de technologie médicale Symetis n’a cessé de se développer depuis son rachat par l’américain Boston Scientific il y a [...]
Vertiflex Announces Appointments to Board of Directors, Ray Baker, MD, and Richard Mott Company milestones demonstrate progress and commercial success of product portfolio CARLSBAD, Calif. – 8 June 2018 – Vertiflex, Inc., a leading innovator of advanced, minimally invasive interventions for spinal stenosis, today announced two new members [...]
CAESAREA, Israel, April 26, 2018 /PRNewswire/ — V-Wave Ltd., an Israel-based company that has developed a proprietary, minimally invasive implanted interatrial shunt device for treating patients with severe symptomatic heart failure (HF), announced today that it has closed a Series C financing of $70 million led by Deerfield Management [...]